Wuxi Fortune Pharmaceutical Co., Ltd.

Form 483 issued September 13, 2023 · Wuxi, China

Inspection
Sep 5 – Sep 13, 2023
Investigator
Niketa Patel
Observations
3
Pages
3
FEI number
3005968356

In short: On September 13, 2023, FDA issued a Form 483 with 3 observations to Wuxi Fortune Pharmaceutical Co., Ltd. in Wuxi, Jiangsu (FEI 3005968356) after an inspection that ran Sep 5 – Sep 13, 2023. The investigator was Niketa Patel. Most observations concern facilities & equipment and production; the most-cited regulation is 21 CFR 211.63 (equipment design, size, and location).

At a glance

Facilities & equipment and production account for 2 of 3 observations.

Facilities & equipment1
Production1
Other1

Most cited: 21 CFR 211.63 (1×) · 211.100 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Equipment used in the manufacture, processing, packing or holding of drug products is…

  2. 02

    Deviation from written production and process control procedures are not recorded and justified…

  3. 03

    to reduce [///™@concentration…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Wuxi Fortune Pharmaceutical Co., Ltd.?

FDA listed 3 observations on this Form 483, mostly about facilities & equipment and production. The most-cited regulation is 21 CFR 211.63 (equipment design, size, and location). The opening words of each observation are shown on this page.

Who inspected Wuxi Fortune Pharmaceutical Co., Ltd.?

Niketa Patel is named on this Form 483, for the inspection of Sep 5 – Sep 13, 2023. Each investigator has a profile showing what they cite most.

When was Wuxi Fortune Pharmaceutical Co., Ltd. inspected by FDA?

The inspection ran Sep 5 – Sep 13, 2023, and the Form 483 is dated September 13, 2023.

How do I get the full Form 483 for Wuxi Fortune Pharmaceutical Co., Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free